These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7854346

  • 21. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
    Buscail L, Estève JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N, Susini C.
    Proc Natl Acad Sci U S A; 1995 Feb 28; 92(5):1580-4. PubMed ID: 7878022
    [Abstract] [Full Text] [Related]

  • 22. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F, Pattarozzi A, Gatti M, Porcile C, Bajetto A, Ferrari A, Culler MD, Florio T.
    Endocrinology; 2008 Sep 28; 149(9):4736-46. PubMed ID: 18566118
    [Abstract] [Full Text] [Related]

  • 23. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade.
    Bito H, Mori M, Sakanaka C, Takano T, Honda Z, Gotoh Y, Nishida E, Shimizu T.
    J Biol Chem; 1994 Apr 29; 269(17):12722-30. PubMed ID: 8175684
    [Abstract] [Full Text] [Related]

  • 24. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
    Viguerie N, Tahiri-Jouti N, Ayral AM, Cambillau C, Scemama JL, Bastié MJ, Knuhtsen S, Estève JP, Pradayrol L, Susini C.
    Endocrinology; 1989 Feb 29; 124(2):1017-25. PubMed ID: 2563240
    [Abstract] [Full Text] [Related]

  • 25. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G.
    Mol Endocrinol; 2001 Oct 29; 15(10):1838-52. PubMed ID: 11579215
    [Abstract] [Full Text] [Related]

  • 26. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
    Hadcock JR, Strnad J, Eppler CM.
    Mol Pharmacol; 1994 Mar 29; 45(3):410-6. PubMed ID: 8145728
    [Abstract] [Full Text] [Related]

  • 27. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
    Reardon DB, Dent P, Wood SL, Kong T, Sturgill TW.
    Mol Endocrinol; 1997 Jul 29; 11(8):1062-9. PubMed ID: 9212054
    [Abstract] [Full Text] [Related]

  • 28. Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2+ mobilization.
    Tomura H, Okajima F, Akbar M, Abdul Majid M, Sho K, Kondo Y.
    Biochem Biophys Res Commun; 1994 Apr 29; 200(2):986-92. PubMed ID: 7910018
    [Abstract] [Full Text] [Related]

  • 29. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism.
    Wilkinson GF, Feniuk W, Humphrey PP.
    Br J Pharmacol; 1997 May 29; 121(1):91-6. PubMed ID: 9146892
    [Abstract] [Full Text] [Related]

  • 30. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells.
    Lauder H, Sellers LA, Fan TP, Feniuk W, Humphrey PP.
    Br J Pharmacol; 1997 Oct 29; 122(4):663-70. PubMed ID: 9375962
    [Abstract] [Full Text] [Related]

  • 31. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines.
    Kuzhikandathil EV, Yu W, Oxford GS.
    Mol Cell Neurosci; 1998 Dec 29; 12(6):390-402. PubMed ID: 9888991
    [Abstract] [Full Text] [Related]

  • 32. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
    Reisine T, Guild S.
    J Pharmacol Exp Ther; 1985 Dec 29; 235(3):551-7. PubMed ID: 2867203
    [Abstract] [Full Text] [Related]

  • 33. Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry.
    Chen L, Tashjian AH.
    Cell Signal; 1999 Jul 29; 11(7):499-505. PubMed ID: 10405760
    [Abstract] [Full Text] [Related]

  • 34. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells.
    Tallent M, Reisine T.
    Mol Pharmacol; 1992 Mar 29; 41(3):452-5. PubMed ID: 1347639
    [Abstract] [Full Text] [Related]

  • 35. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
    Horie K, Itoh H, Tsujimoto G.
    Mol Pharmacol; 1995 Sep 29; 48(3):392-400. PubMed ID: 7565618
    [Abstract] [Full Text] [Related]

  • 36. Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus.
    Hernández-Pinto AM, Puebla-Jiménez L, Perianes-Cachero A, Arilla-Ferreiro E.
    J Nutr Biochem; 2013 May 29; 24(5):848-58. PubMed ID: 22902329
    [Abstract] [Full Text] [Related]

  • 37. Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity.
    Florio T, Pan MG, Newman B, Hershberger RE, Civelli O, Stork PJ.
    J Biol Chem; 1992 Dec 05; 267(34):24169-72. PubMed ID: 1360008
    [Abstract] [Full Text] [Related]

  • 38. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    Panetta R, Greenwood MT, Warszynska A, Demchyshyn LL, Day R, Niznik HB, Srikant CB, Patel YC.
    Mol Pharmacol; 1994 Mar 05; 45(3):417-27. PubMed ID: 7908405
    [Abstract] [Full Text] [Related]

  • 39. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
    Barbieri F, Pattarozzi A, Gatti M, Aiello C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD, Florio T.
    Am J Physiol Endocrinol Metab; 2009 Nov 05; 297(5):E1078-88. PubMed ID: 19706788
    [Abstract] [Full Text] [Related]

  • 40. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization.
    Vanetti M, Vogt G, Höllt V.
    FEBS Lett; 1993 Oct 04; 331(3):260-6. PubMed ID: 8104154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.